Posters

The Combination of ACT and INDUKINE™ Therapy Leads to Improved Antitumor Immunity in Mouse Solid Tumors

Dwyer et al. 2023, 2023

Exclusive content

If you are a customer with an existing My Lunaphore account

or

Fill out the form to unlock the content

Open form

Related Articles

Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer

Posted on 01 Nov 2023

Automation of Proximity Ligation Immunoassay for interaction between PD-L1 and PD-1 detection in the tumor microenvironment using microfluidic-based systems

Posted on 01 Apr 2023